Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Aug. 27, 2018. Jeffrey Trauring.

Executive Summary

A federal appeals court has sent a dispute between Medtronic and the US Internal Revenue Service back to Tax Court, after finding the US Tax Court hadn’t justified a decision to slash Medtronic’s liability. The long-running dispute stems from IRS suspicions that the company was trying to reduce its US tax liability by shifting its lead production to Puerto Rico. See what Medtronic spokesman Jeffrey Trauring said about it here.

"It is important to note that this is a procedural decision and not a ruling on the merits. The Eighth Circuit determined that it needed additional analysis from the Tax Court before it could rule on the merits of the appeal. We still believe our initially filed tax returns were correct and will continue to defend our position." –Jeffrey Trauring, spokesman, Medtronic PLC

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel